These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22798259)

  • 1. Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles.
    Prasad S; Cody V; Saucier-Sawyer JK; Fadel TR; Edelson RL; Birchall MA; Hanlon DJ
    Pharm Res; 2012 Sep; 29(9):2565-77. PubMed ID: 22798259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly Lactic-co-Glycolic Acid Nanoparticles Containing Human Gastric Tumor Lysates as Antigen Delivery Vehicles for Dendritic Cell-Based Antitumor Immunotherapy.
    Kohnepoushi C; Nejati V; Delirezh N; Biparva P
    Immunol Invest; 2019 Nov; 48(8):794-808. PubMed ID: 31094258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
    Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
    Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.
    Hanlon DJ; Aldo PB; Devine L; Alvero AB; Engberg AK; Edelson R; Mor G
    Am J Reprod Immunol; 2011 Jun; 65(6):597-609. PubMed ID: 21241402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells.
    Solbrig CM; Saucier-Sawyer JK; Cody V; Saltzman WM; Hanlon DJ
    Mol Pharm; 2007; 4(1):47-57. PubMed ID: 17217312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.
    Prasad S; Cody V; Saucier-Sawyer JK; Saltzman WM; Sasaki CT; Edelson RL; Birchall MA; Hanlon DJ
    Nanomedicine; 2011 Feb; 7(1):1-10. PubMed ID: 20692374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer.
    Sheikhzadeh S; Delirezh N; Hobbenaghi R
    Biomed Pharmacother; 2021 Oct; 142():111962. PubMed ID: 34358752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.
    Fargnoli AS; Mu A; Katz MG; Williams RD; Margulies KB; Weiner DB; Yang S; Bridges CR
    J Transl Med; 2014 Jun; 12():171. PubMed ID: 24934216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders.
    Kang J; Lambert O; Ausborn M; Schwendeman SP
    Int J Pharm; 2008 Jun; 357(1-2):235-43. PubMed ID: 18384984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of DC-mediated anti-leukemic immunity in vitro by WT1 antigen and CpG co-encapsulated in PLGA microparticles.
    Zhang L; Zhao S; Duan J; Hu Y; Gu N; Xu H; Yang XD
    Protein Cell; 2013 Dec; 4(12):887-9. PubMed ID: 24258060
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
    Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA
    Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases.
    Pirooznia N; Hasannia S; Lotfi AS; Ghanei M
    J Nanobiotechnology; 2012 May; 10():20. PubMed ID: 22607686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.
    San Román B; Gómez S; Irache JM; Espuelas S
    J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer.
    Gross BP; Wongrakpanich A; Francis MB; Salem AK; Norian LA
    AAPS J; 2014 Nov; 16(6):1194-203. PubMed ID: 25224145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
    Cruz LJ; Rosalia RA; Kleinovink JW; Rueda F; Löwik CW; Ossendorp F
    J Control Release; 2014 Oct; 192():209-18. PubMed ID: 25068703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
    Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP
    Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.